Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Company Profile

(I) Technology and R&D advantages After years of development and accumulation, the company has established a complete set of independent core technology system, with mature dangerous chemical processes such as fluorinization, hydrogenation, alkylation, nitrification, oxidation, and large-scale production technologies such as high-temperature reactions (500-600 degrees Celsius), low-temperature crystallization (minus 40-50 degrees Celsius). The company's core technology covers from basic chemical raw materials, pharmaceutical intermediates, raw materials to pharmaceutical preparations, as well as lithium battery materials. The products involve anti-bacterial drugs, antiviral drugs, electrolyte key materials, etc. The core technology system is sound, covering a wide range of products, and a number of technologies have been identified as domestically or internationally leading level, and has won many provincial science and technology progress awards. These core technologies are conducive to improving production efficiency and product quality, reducing production costs, and reducing energy consumption, pollutant emissions and safety risks. (II) Product quality advantages After years of continuous improvement and innovation, relying on advanced product technology, relatively sound production management system and strict product quality standards, the company's product quality is at a high level in the industry. In order to ensure product quality, the company has strict admission standards for qualified suppliers. Generally, it will choose large-scale chemical production enterprises or traders to purchase raw materials, If necessary, audits will also be conducted on suppliers. In addition, because the company has established an integrated industrial chain from organic chemical raw materials to intermediates, API to pharmaceutical preparations, it avoids the quality risks caused by the purchase of numerous raw materials, which further ensuring the quality of the company's products. (III) Advantages of integrated industrial chain The company has established an integrated industrial chain from initial materials to intermediates, API to pharmaceutical preparations in the field of nitroimidazoles. It has also initially established a relatively complete industrial chain in the field of Lovir series anti-herpes drugs, and strives to build an integrated industrial chain. At present, the products of the Lovir series anti-herpes virus drug industry chain include triammonium, guanine, diacetyl guanine, diacetyl acyclovir, and acyclovir, which will continue to expand to the upstream and downstream of the industrial chain in the future. The integrated industrial chain enables the main raw materials needed for the production of the company's products to be self-produced, which is conducive to reducing the company's production costs and improving the market competitiveness of products. In addition, the integrated industrial chain enables the company to effectively avoid the sharp increase in costs and limited production caused by the sharp fluctuations in supply and demand of a raw material market in the industrial chain, which helps the company maintain an adequate supply and provide stable supply to downstream customers. Due to the above characteristics, the company is less limited in market bargaining and has a large adjustment space. When the market fluctuates, it can adjust the pricing strategy in time according to its own actual situation, so as to effectively resist risks and greatly improve the market competitiveness of products. (IV) Advantages of product diversification The company's main products include glyoxal, glyoxylic acid, 2-methyl-5-nitroimidazole, metronidazole, guanine and lithium hexafluorophosphate, etc., involving the basic chemical industry, API, pharmaceutical intermediates, pharmaceutical preparations and new energy fields. In the terms of the pharmaceutical industry chain, it is also engaging in the two major fields of anti-bacterial drugs and antiviral drugs simultaneously. Each product is connected and independent of each other, jointly building the company's entire industry chain layout in relevant industries. The company has a diverse range of products and involves multiple segmented industries, which effectively avoids dependence on a single variety and can effectively diversify business risks, especially the risk of cyclical fluctuations in the industry. (V) Scale advantage The production capacity and market share of the company's main products, such as API Metronidazole ; 2-methyl-5-nitroimidazole, key intermediate of nitroimidazole drugs, Glyoxal, key chemical raw material; Glyoxylic acid, key intermediate for the synthesis of amoxicillin; and Guanine, the key intermediate of Lovir,etc. occupies a leading position in the domestic and even global market , the industry position is prominent, and the scale advantage is obvious. The advantage of scale makes the company in a favorable position in the market competition, which can enable the company to give full play to the scale effect, reduce production costs, and enable the company to guarantee a stable supply to customers. In addition, the scale advantage also gives the company a strong ability to resist the risk of cyclical fluctuations in the industry. (VI) Advantages of customer and marketing network After years of market development and customer accumulation, the company has established a marketing network covering 31 provinces, cities and autonomous regions across the country, and its products in overseas markets have been sold to dozens of countries and regions such as Asia, Europe, Africa and the Americas. Due to the rich product line, the company's customer base is diversified, covering production, wholesale and retail enterprises in the pharmaceutical field and fine chemical industry. With its high-quality products and outstanding industry status, the company has established a high reputation in the industry and won a good reputation. It has established a good cooperative relationship with well-known domestic pharmaceutical enterprises such as The united laboratories,Sinopharm Group, CSPC Pharmaceutical Group, Harbin Pharmaceutical Group, Apeloa Pharmaceutical, Kelun Pharmaceutical, and other international well-known enterprises such as Sanofi, Baxter and Solvay.etc. The perfect marketing network, diversification and high-quality customer resources have brought stable market demand to the company. (VII) Advantages of the management team Most of the members of the company's management team have been working in the industry for many years. They have a deep professional background and rich experience. They are familiar with the characteristics and trends of the development of the industry. They have a deep understanding and keen market insight into the industry. They can actively comply with the development trends of the industry and changes in market demand, and make the right decision timely The decision has enabled the company to maintain strong competitiveness and established the company's current market leading position. Most of the company's management team members, especially the core executives, have been engaged in management work in the company since the establishment of the company. The management team has been growing with the company for a long time and has strong team stability.